Evidence map›Paper›PMID 31953349›Full record

ReviewInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2020

Current and novel mapping substances in gynecologic cancer care.

Lea A Moukarzel, Jacqueline Feinberg, Evan J Levy, Mario M Leitao

Open access · greenAbstract readReview
In one paragraph

Review in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Lea A MoukarzelGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jacqueline FeinbergGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Evan J LevyNorthwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Mario M LeitaoGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA leitaom@mskcc.org.
Memorial Sloan Kettering Cancer Center · USCornell University · USNorthwestern University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Many tracers have been introduced into current medical practice with the purpose of improving lymphatic mapping techniques, anatomic visualization, and organ/tissue perfusion assessment. Among them, three tracers have dominated the field: indocyanine green, technetium-99m radiocolloid (Tc99

Indexed as

FemaleGenital Neoplasms, FemaleHumansLymphatic MetastasisLymph NodesNeoplasm StagingPrognosisRandomized Controlled Trials as TopicSentinel Lymph NodeSentinel Lymph Node Biopsycervical canceroperativesentinel lymph nodesurgical proceduresuterine cancervulvar and vaginal cancer

Identifiers

PMID31953349
PMCPMC7375198
OpenAlexW2998969364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.